Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Gel vs Triple Combination Cream for Melasma
NCT07345507Completed
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Feb 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of metformin 1% gel in melasma (2 arms), sponsored by Jinnah Postgraduate Medical Centre. Primary endpoint: Proportion of participants with >=50% reduction in MASI score at 12 weeks. Started Feb 2025; status: completed.
02
Drugs
metformin 1% gel
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07345507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07345507.